Engineering an AIEgen-based platform integrating CRISPR/Cas9 to remodel the tumor microenvironment and reinforce photo-immunotherapy against glioblastom. - Luo G; Ma F; Yang Y; Yang C; Li X; Xie J; Xiong K; Chen P; Ma K; Zhao Z; Tang BZ; Duo Y (Signal transduction and targeted therapy, 2026)